Long Term Outcomes of Autologous Bone Marrow Mononuclear Cells Transplantation on Patients with Idiopathic Dilated Cardiomyopathy

章轶琦,黄榕翀,姚康,钱菊英,牛玉宏,孙爱军,邹云增,葛均波

DOI: https://doi.org/10.3969/j.issn.1004-8812.2007.03.011

2007-01-01

Abstract:Objective To identify long-term outcomes of intracoronary transplantation of autologous bone marrow mononuclear cells(BMCs)in idiopathic dilated cardiomyopathy(IDC)patients in addition to standard therapy.Methods Additional to standard drug therapy,eighteen patients with idiopathic dilated cardiomyopathy were enrolled and divided randomly into the transplantation group(n=10)and the control group(n=8).The baseline clinical characteristics of the two groups were comparable.Patients in the transplantation group received percutaneous coronary autologous BMCs transplantation.Blood routine test,hepatic function,renal function,glucose,triglyeride(TG),cholesterol,low density cholesterol(LDL-C),high density cholesterol(HDL-C),uric acid(UA),and high sensitive C-reactive protein(hsCRP)were measured before and at 12 months after transplantation.All patients also received ultrasonic echocardiography,Holter,six-minute-walk test and magnetic resonance imaging before and at 12 months after the procedure.The study end-point is death from any cause and the duration of hospital stay per annumn was recorded.Results The distance of six-minute-walk in the transplantation group increased after 12 months compared with the pre-transplantation level(521.7±78.2 m vs 321.5±63.7 m,P0.05).Changes in LVEF after transplantation of the transplantation group showed statistical difference compared with that of control group(3.1%±4.5% vs-2.4%±4.6%,P=0.019),but there was no statistical difference in the absolute value of LVEF between the 2 groups(P0.05).Statistical difference was also found in left ventricular end diastolic diameeter(LVEDd)between the post-transplantation group and the control(67.2±1.0 mm vs 69.5±1.1 mm,P0.01).No malignent arrhythmias and major adverse effects were recorded throughout the follow up.Conclusion Autologous bone marrow mononuclear cells transplantation can prolong the distance of six-minute-walk,decrease the LVEDd and is safe for idiopathic dilated cardiomyopathy patients.